Short Interest in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Decreases By 96.4%

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 400 shares, a drop of 96.4% from the March 31st total of 11,000 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 40,900 shares, the short-interest ratio is currently 0.0 days.

Hedge Funds Weigh In On Bluejay Diagnostics

A hedge fund recently bought a new stake in Bluejay Diagnostics stock. Armistice Capital LLC acquired a new stake in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 24,230 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned approximately 1.95% of Bluejay Diagnostics at the end of the most recent reporting period. Institutional investors own 18.47% of the company’s stock.

Bluejay Diagnostics Trading Up 14.5 %

Shares of Bluejay Diagnostics stock traded up $0.08 during trading on Friday, hitting $0.63. 99,128 shares of the stock traded hands, compared to its average volume of 46,286. The firm has a market cap of $1.70 million, a P/E ratio of -0.07 and a beta of 0.85. Bluejay Diagnostics has a 52-week low of $0.47 and a 52-week high of $13.98. The stock’s fifty day simple moving average is $0.74 and its 200 day simple moving average is $1.86.

Bluejay Diagnostics (NASDAQ:BJDX) last announced its quarterly earnings results on Thursday, March 28th. The company reported ($1.78) EPS for the quarter, missing the consensus estimate of ($0.68) by ($1.10).

About Bluejay Diagnostics

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.